Shandong Pharmaceutical Glass Co Ltd (600529) — Financial Flexibility Index
Shandong Pharmaceutical Glass Co Ltd (600529) has a Financial Flexibility Index of 0.11x as of December 2025. Free cash flow of CN¥194.64 Million (operating CF CN¥41.46 Million minus capex CN¥153.18 Million) represents 0% of total liabilities (CN¥1.75 Billion). Check Shandong Pharmaceutical Glass Co Ltd investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Shandong Pharmaceutical Glass Co Ltd Financial Flexibility Index (2001–2025)
Historical Financial Flexibility Index trend for Shandong Pharmaceutical Glass Co Ltd across 25 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Shandong Pharmaceutical Glass Co Ltd.
Annual Financial Flexibility Index for Shandong Pharmaceutical Glass Co Ltd (2001–2025)
Year-by-year free cash flow to debt coverage for Shandong Pharmaceutical Glass Co Ltd. Explore 600529 debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.46x | CN¥808.79 Million | CN¥576.92 Million | CN¥1.75 Billion | ▼ -45.6% |
| 2024 | 0.85x | CN¥1.81 Billion | CN¥1.17 Billion | CN¥2.13 Billion | ▼ -11.8% |
| 2023 | 0.96x | CN¥1.72 Billion | CN¥1.05 Billion | CN¥1.78 Billion | ▲ +82.4% |
| 2022 | 0.53x | CN¥963.16 Million | CN¥252.44 Million | CN¥1.82 Billion | ▼ -41.1% |
| 2021 | 0.90x | CN¥1.56 Billion | CN¥750.44 Million | CN¥1.74 Billion | ▲ +11.2% |
| 2020 | 0.81x | CN¥1.10 Billion | CN¥566.01 Million | CN¥1.37 Billion | ▼ -11.8% |
| 2019 | 0.91x | CN¥1.19 Billion | CN¥599.05 Million | CN¥1.30 Billion | ▲ +23.4% |
| 2018 | 0.74x | CN¥813.16 Million | CN¥465.77 Million | CN¥1.10 Billion | ▲ +18.9% |
| 2017 | 0.62x | CN¥579.03 Million | CN¥411.96 Million | CN¥929.84 Million | ▼ -23.8% |
| 2016 | 0.82x | CN¥703.11 Million | CN¥506.53 Million | CN¥860.62 Million | ▲ +10.3% |
| 2015 | 0.74x | CN¥544.75 Million | CN¥389.63 Million | CN¥735.61 Million | ▲ +28.2% |
| 2014 | 0.58x | CN¥400.16 Million | CN¥266.63 Million | CN¥692.56 Million | ▼ -6.9% |
| 2013 | 0.62x | CN¥419.09 Million | CN¥268.60 Million | CN¥675.48 Million | ▲ +176.7% |
| 2012 | 0.22x | CN¥150.62 Million | CN¥28.52 Million | CN¥671.80 Million | ▼ -70.6% |
| 2011 | 0.76x | CN¥492.15 Million | CN¥274.63 Million | CN¥644.80 Million | ▲ +42.3% |
| 2010 | 0.54x | CN¥417.38 Million | CN¥217.01 Million | CN¥778.34 Million | ▼ -9.1% |
| 2009 | 0.59x | CN¥367.71 Million | CN¥249.27 Million | CN¥623.51 Million | ▲ +26.0% |
| 2008 | 0.47x | CN¥250.15 Million | CN¥91.76 Million | CN¥534.52 Million | ▼ -6.8% |
| 2007 | 0.50x | CN¥283.46 Million | CN¥122.63 Million | CN¥564.66 Million | ▲ +137.7% |
| 2006 | 0.21x | CN¥149.06 Million | CN¥78.47 Million | CN¥705.86 Million | ▼ -7.8% |
| 2005 | 0.23x | CN¥129.18 Million | CN¥44.09 Million | CN¥564.27 Million | ▼ -30.1% |
| 2004 | 0.33x | CN¥142.42 Million | CN¥-3.70 Million | CN¥434.85 Million | ▼ -69.3% |
| 2003 | 1.07x | CN¥331.09 Million | CN¥59.35 Million | CN¥310.80 Million | ▲ +40.9% |
| 2002 | 0.76x | CN¥221.75 Million | CN¥109.26 Million | CN¥293.28 Million | ▲ +240.6% |
| 2001 | 0.22x | CN¥53.92 Million | CN¥28.60 Million | CN¥242.90 Million | — |